| Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis S Parvez, G Yadagiri, MR Gedda, A Singh, OP Singh, A Verma, S Sundar, ... Scientific Reports 10 (1), 12243, 2020 | 90 | 2020 |
| Formulation, characterization and in vitro anti-leishmanial evaluation of amphotericin B loaded solid lipid nanoparticles coated with vitamin B12-stearic acid conjugate A Singh, G Yadagiri, S Parvez, OP Singh, A Verma, S Sundar, ... Materials Science and Engineering: C 117, 111279, 2020 | 40 | 2020 |
| Recuperating biopharmaceutical aspects of amphotericin B and paromomycin using a chitosan functionalized nanocarrier via oral route for enhanced anti-leishmanial activity S Parvez, G Yadagiri, A Karole, OP Singh, A Verma, S Sundar, ... Frontiers in cellular and infection microbiology 10, 570573, 2020 | 30 | 2020 |
| Evaluation of Safety and Antileishmanial Efficacy of Amine Functionalized Carbon-Based Composite Nanoparticle Appended With Amphotericin B: An in vitro and … MR Gedda, P Madhukar, AK Vishwakarma, V Verma, AK Kushwaha, ... Frontiers in chemistry 8, 510, 2020 | 26 | 2020 |
| Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria L Gujjari, H Kalani, SK Pindiprolu, BP Arakareddy, G Yadagiri Parasite Epidemiology and Control 17, e00244, 2022 | 24 | 2022 |
| Coalition of biological agent (melatonin) with chemotherapeutic agent (amphotericin B) for combating visceral leishmaniasis via oral administration of modified solid lipid … S Parvez, G Yadagiri, K Arora, A Javaid, AK Kushwaha, OP Singh, ... ACS Biomaterials Science & Engineering 9 (6), 2902-2910, 2021 | 17 | 2021 |
| Improvising anti-leishmanial activity of amphotericin B and paromomycin using co-delivery in d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) tailored nano-lipid … S Parvez, G Yadagiri, A Singh, A Karole, OP Singh, S Sundar, ... Chemistry and Physics of Lipids 231, 104946, 2020 | 16 | 2020 |
| Carboxymethyl chitosan modified lipid nanoformulations as a highly efficacious and biocompatible oral anti-leishmanial drug carrier system A Singh, G Yadagiri, M Negi, AK Kushwaha, OP Singh, S Sundar, ... International Journal of Biological Macromolecules 204, 373-385, 2022 | 15 | 2022 |
| Immunotherapy and immunochemotherapy in combating visceral leishmaniasis G Yadagiri, A Singh, K Arora, SL Mudavath Frontiers in Medicine 10, 1096458, 2023 | 9 | 2023 |
| Sensible graphene oxide differentiates macrophages and Leishmania: a bio-nano interplay in attenuating intracellular parasite A Singh, S Sharma, G Yadagiri, S Parvez, R Gupta, NK Singhal, ... RSC advances 10 (46), 27502-27511, 2020 | 9 | 2020 |
| Chemotherapy and experimental models of visceral leishmaniasis G Yadagiri, PP Singh Infectious Diseases and Your Health, 63-97, 2018 | 9 | 2018 |
| An orf-virus (ORFV)-based vector expressing a consensus H1 hemagglutinin provides protection against diverse swine influenza viruses GM do Nascimento, D Bugybayeva, V Patil, J Schrock, G Yadagiri, ... Viruses 15 (4), 994, 2023 | 7 | 2023 |
| A split influenza vaccine formulated with a combination adjuvant composed of alpha-d-glucan nanoparticles and a STING agonist elicits cross-protective immunity … V Patil, JF Hernandez-Franco, G Yadagiri, D Bugybayeva, S Dolatyabi, ... Journal of Nanobiotechnology 20 (1), 477, 2022 | 6 | 2022 |
| Hijacking the intrinsic vitamin B 12 pathway for the oral delivery of nanoparticles, resulting in enhanced in vivo anti-leishmanial activity A Singh, G Yadagiri, A Javaid, KK Sharma, A Verma, OP Singh, S Sundar, ... Biomaterials Science 10 (19), 5669-5688, 2022 | 4 | 2022 |
| An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters K Tabynov, M Solomadin, N Turebekov, M Babayeva, G Fomin, ... Scientific Reports 13 (1), 12115, 2023 | 3 | 2023 |
| Enkephalins as a therapeutic intervention for visceral leishmaniasis G Yadagiri, SL Mudavath Medical hypotheses 144, 109956, 2020 | 3 | 2020 |
| Molecular identification of Echinococcus granulosus sensu lato by mitochondrial COX1 and SSU-rDNA markers in dogs in the west of Iran SR Mirbadie, M Zivdari, H Kalani, MR Vafaei, S Izadi, Z Jabalameli, ... Gene Reports 19, 100616, 2020 | 2 | 2020 |
| SARS-CoV-2 Spike receptor-binding domain entrapped in mannose-conjugated chitosan nanoparticle vaccine delivered intranasal elicits local and systemic Th1 and Th2 immune … K Tabynov, M Solomadin, N Turebekov, M Babayeva, G Fomin, ... | 1 | 2022 |
| Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis P Shabi, Y Ganesh, GM Rao, S Aakriti, OP Singh, V Anurag, S Shyam, ... Scientific Reports (Nature Publisher Group), 2020 | 1 | 2020 |
| Current understanding and future directions of cruciferous vegetables and their phytochemicals to combat neurological diseases R Kakarla, P Karuturi, Q Siakabinga, M Kasi Viswanath, N Dumala, ... Phytotherapy Research, 2024 | | 2024 |
Shyam SundarDistinguished Professor of Medicine, Banaras Hindu UniversityVerified email at bhu.ac.in
